Replies to post #98462 on Amarantus Bioscience Holdings Inc (AMBS)

[Mikehbr]

Tell me that late filing is not a problem. AMBS was delisted from OTCBB last year for late filing.

GC is dropping indicators that 2014 is the year to uplist. He has been using the carrot and stick approach for the last to years.

Uplist back to OTCBB? GC does not seem to understand that his business model is built for JV. AMBS does not have the funds, staff, or logistical expertise to take ANY of AMBS' pipeline to market. They need the confidence of big pharma to get the product to market.

What is funny is that in TODAYS blog about being "on-track", he goes on to say: "As a result of these steps, we are in a position to initiate a partnering process for the CLIA commercial launch of LymPro in the second half of 2014. - See more at: http://www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/commercialization-track-2014-updating-lympro-test-progress/#sthash.RvCje3hj.dpuf";. Initiate that partnership from a position of weakness. Way to go.

"On-Track" to "initiate a partnering"... uh huh.. GC you are the CEO. This fail is on you.